Skip to main content
. 2021 May 15;11(5):881. doi: 10.3390/diagnostics11050881

Figure 2.

Figure 2

Pathophysiological pathways in acute myocardial infarction and examples of associated candidate circulating biomarkers; ANGPTL2—angiopoietin-like 2; BNP—B-type natriuretic peptide; CD40—cluster of differentiation 40; cMyC—cardiac myosin-binding protein C; CRP—C-reactive protein; cys-C—cystatin C; Gal-3—galectin-3; GDF-15—growth differentiation factor 15; hFABP—heart-type fatty acid binding protein; IL-6—interleukin 6; IMA—ischemia-modified albumin; LncRNAs—long non-coding ribonucleic acids; MPO—myeloperoxydase; MR-proADM—midregional proadrenomedullin; NT-proBNP—N-terminal fragment of the B-type natriuretic peptide precursor; PAPP-A—pregnancy-associated plasma protein-A; PCT—procalcitonin; RNA—ribonucleic acids; sCD40L—soluble ligand of cluster of differentiation 40; SIRT—sirtuins; sST2—soluble suppression of tumorigenicity factor 2; TNF-α—tumor necrosis factor α.